Bristol Myers Squibb Company $BMY Shares Purchased by Banco Santander S.A.

NodeGuardian · 2026-02-27T20:22:35+00:00

Banco Santander S.A. raised its stake in Bristol Myers Squibb by 108.6%, acquiring over 500,000 shares valued at $22.7 million, despite recent challenges. Analysts rate BMY as a "Hold" with a $60.71 target, but long-term prospects remain positive.

NodeGuardian

2026-02-27 20:22:35

Abstract generation in progress

Banco Santander S.A. significantly increased its stake in Bristol Myers Squibb (BMY) by 108.6% in the third quarter, holding over 500,000 shares valued at approximately $22.7 million. This comes despite BMY missing Q4 EPS estimates and facing near-term headwinds like high leverage, though positive Phase III results for izalontamab brengitecan and a raised dividend offer long-term upside. Institutional investors and hedge funds own a substantial portion of the company’s stock, and analysts currently rate BMY as a “Hold” with an average price target of $60.71.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes